trending Market Intelligence /marketintelligence/en/news-insights/trending/96bqj2bfjh_rgoxdcxu4yq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Biostage adds hospital executive to board

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Biostage adds hospital executive to board

Holliston, Mass.-based Biostage Inc. named James Shmerling as a board member.

Shmerling is the president and CEO of Connecticut Children's Medical Center.

"Biostage is collaborating with Connecticut Children's Medical Center to translate our Cellframe technology from pre-clinical studies to clinical trials to address pediatric esophageal atresia, and the addition of Jim to our board supports the vision of this collaboration," Biostage CEO James McGorry said in a statement.

Biostage is a biotechnology company that engages in developing bioengineered organ implants.